This team may include your primary care doctor, a cardiologist (heart specialist), and possibly an endocrinologist (diabetes specialist)
How long does it take to see weight loss results with Ozempic
Today, Novo Nordisk estimates that just under 20 million people are treated with GLP-1 drugs.4 Given a well-stocked pipeline, a substantial global addressable population (the obese population alone is projected to exceed 1.2 billion by 20305), and in light of the very beneficial clinical profile of these drugs, it is plausible that over 100 million patients worldwide will be treated with GLP-1s in the near future
However, researchers are exploring its effects on asthma because it has anti-inflammatory properties
It enhances fat utilization, which leads to improved endurance during prolonged exercise
The major semaglutide and tirzepatide trials focused on weight, blood sugar, and well-known safety endpoints, so menstrual cycle changes and temperature complaints were not standard questions on the case-report forms